TELCON RF PHARMACEUTICAL. Inc. (KOSDAQ:200230)

TELCON RF PHARMACEUTICAL. Revenue

TELCON RF PHARMACEUTICAL. had revenue of 10.03B KRW in the quarter ending June 30, 2025, with 13.63% growth. This brings the company's revenue in the last twelve months to 41.02B, up 6.16% year-over-year. In the year 2024, TELCON RF PHARMACEUTICAL. had annual revenue of 37.87B with 4.29% growth.

• Revenue (ttm): 41.02B
• Revenue Growth: +6.16%
• P/S Ratio: 1.13
• Revenue / Employee: 325.52M
• Employees: 126
• Market Cap: 46.18B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	37.87B	1.56B	4.29%
Dec 31, 2023	36.31B	8.48B	30.46%
Dec 31, 2022	27.83B	-10.01B	-26.46%
Dec 31, 2021	37.84B	4.70B	14.18%
Dec 31, 2020	33.14B	-23.45B	-41.44%